Confluence Investment Management’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-167,040
Closed -$5.47M 322
2022
Q2
$5.47M Sell
167,040
-30,130
-15% -$952K 0.09% 135
2022
Q1
$5.18M Buy
197,170
+12,570
+7% +$307K 0.07% 150
2021
Q4
$4.38M Buy
184,600
+3,837
+2% +$94.7K 0.06% 161
2021
Q3
$4.53M Buy
180,763
+1,230
+0.7% +$31.3K 0.06% 159
2021
Q2
$4.67M Buy
179,533
+4,256
+2% +$116K 0.06% 158
2021
Q1
$4.49M Buy
175,277
+21,998
+14% +$564K 0.06% 154
2020
Q4
$3.07M Buy
153,279
+2,669
+2% +$52.3K 0.05% 175
2020
Q3
$2.58M Sell
150,610
-1,909
-1% -$36.1K 0.04% 169
2020
Q2
$3.33M Sell
152,519
-2,560
-2% -$58.6K 0.06% 158
2020
Q1
$3.59M Sell
155,079
-3,367
-2% -$97.9K 0.07% 151
2019
Q4
$4.07M Buy
158,446
+1,539
+1% +$49.3K 0.07% 161
2019
Q3
$5M Sell
156,907
-1,539
-1% -$44.9K 0.08% 150
2019
Q2
$4.07M Sell
158,446
-166,837
-51% -$4.25M 0.07% 161
2019
Q1
$8.26M Sell
325,283
-475,295
-59% -$14.2M 0.14% 115
2018
Q4
$27.2M Sell
800,578
-71,424
-8% -$2.32M 0.51% 55
2018
Q3
$31.1M Sell
872,002
-88,672
-9% -$3.13M 0.53% 56
2018
Q2
$33.1M Sell
960,674
-32,677
-3% -$1.15M 0.58% 52
2018
Q1
$33.4M Sell
993,351
-28,741
-3% -$910K 0.62% 51
2017
Q4
$39M Sell
1,022,092
-22,069
-2% -$881K 0.71% 49
2017
Q3
$39.2M Buy
1,044,161
+585,088
+127% +$20.6M 0.75% 46
2017
Q2
$17.1M Buy
459,073
+362,326
+375% +$13.1M 0.35% 63
2017
Q1
$3.8M Buy
96,747
+16,583
+21% +$622K 0.08% 138
2016
Q4
$2.79M Buy
80,164
+8,355
+12% +$328K 0.07% 155
2016
Q3
$2.82M Buy
71,809
+2,134
+3% +$85.1K 0.07% 154
2016
Q2
$2.63M Buy
69,675
+42,928
+160% +$1.44M 0.07% 157
2016
Q1
$1.03M Buy
+26,747
New +$996K 0.03% 189

Other funds holding NTUS

Confluence Investment Management's NTUS Position: Q3 2022 in Review

Confluence Investment Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 167,040 shares — an estimated $5.47M sold.

Confluence Investment Management first reported a position in NTUS in Q1 2016 and held it in 26 quarters. The position peaked at $39.2M in Q3 2017. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Confluence Investment Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Confluence Investment Management sold 167,040 Natus Medical Inc shares in Q3 2022, an estimated $5.47M.
  • Confluence Investment Management first reported a position in Natus Medical Inc in Q1 2016 and held it in 26 quarters.
  • Confluence Investment Management's Natus Medical Inc position peaked at $39.2M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Confluence Investment Management's 13F filing for Q3 2022, filed 3 Oct 2022.